Literature DB >> 9915988

Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice.

S A Robertson1, C T Roberts, K L Farr, A R Dunn, R F Seamark.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been identified as a potentially important mediator of intercellular communication in the female reproductive tract, with principal target cells being the large populations of myeloid leukocytes in the cycling and pregnant uterus, the preimplantation embryo, and trophoblast cells of the developing placenta. To determine the physiological significance of this cytokine in reproduction, the fertility of genetically GM-CSF-deficient (GM-/-) mice was examined. Implantation rates were normal in GM-/- mice, and viable pups were produced. However, the mean litter sizes of GM-/- x GM-/- breeding pairs were 25% smaller at weaning than those of GM+/- x GM+/- pairs, due to fetal death late in gestation and early in postnatal life, with a disproportionate loss of male pups. On Day 17 of pregnancy, the mean number of resorbing and malformed fetuses was twice as high in pregnant GM-/- females (21%, vs. 11% in GM+/- females); the mean fetal weight and the mean fetal:placental ratio in surviving conceptuses were diminished by 7% and 6%, respectively; and the number of very small fetuses (< 500 mg) was 9-times as high (23% vs. 2.5%). Mortality during the first 3 wk of life was 4.5-times as high in pups born to GM-/- mothers (9%, vs. 2% in GM+/- females), and diminished size persisted in GM-/- pups, particularly males, into adulthood. The detrimental effect of maternal GM-CSF deficiency was less apparent when GM-/- females were mated with GM+/+ males; litter sizes at birth and at weaning were not significantly smaller than in GM+/- matings, and fetal weights and fetal:placental ratios were also comparable. When polymerase chain reaction was used to genotype embryonic tissue in heterozygote matings, GM-/- fetuses from GM-/- females were found to be smaller than their GM+/- littermates and smaller than GM-/- fetuses gestated in GM+/- females. The size and distribution of uterine granulocyte and macrophage populations were normal during the estrous cycle, during early pregnancy, and in midgestation. Analysis of placental structure revealed that the ratio of labyrinthine to spongiotrophoblast areas was reduced by approximately 28% in GM-/- placentae, and the proportion of vacuolated trophoblast "glycogen cells" in the spongiotrophoblast layer was diminished. Compromised placental function as a result of subtle developmental aberrations may therefore partially account for embryonic growth retardation in GM-CSF-deficient mice. Collectively, these studies show that fetal growth and viability are jeopardized in the absence of maternal GM-CSF. The detrimental effects are most clearly evident when the conceptus is also GM-CSF deficient, suggesting that GM-CSF of either maternal or fetal origin is required for optimal growth and survival of the fetus in mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915988     DOI: 10.1095/biolreprod60.2.251

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  28 in total

1.  CD1d and invariant NKT cells at the human maternal-fetal interface.

Authors:  Jonathan E Boyson; Basya Rybalov; Louise A Koopman; Mark Exley; Steven P Balk; Frederick K Racke; Frederick Schatz; Rachel Masch; S Brian Wilson; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

Review 2.  Intravenous immunoglobulin and recurrent pregnancy loss.

Authors:  Howard J A Carp; Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  Maternal tract factors contribute to paternal seminal fluid impact on metabolic phenotype in offspring.

Authors:  John J Bromfield; John E Schjenken; Peck Y Chin; Alison S Care; Melinda J Jasper; Sarah A Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

4.  Cortisol inhibits CSF2 and CSF3 via DNA methylation and inhibits invasion in first-trimester trophoblast cells.

Authors:  Arianna Smith; Elizabeth Witte; Devin McGee; Jason Knott; Kavita Narang; Karen Racicot
Journal:  Am J Reprod Immunol       Date:  2017-08-28       Impact factor: 3.886

5.  Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro.

Authors:  T T Piltonen; J C Chen; M Khatun; M Kangasniemi; A Liakka; T Spitzer; N Tran; H Huddleston; J C Irwin; L C Giudice
Journal:  Hum Reprod       Date:  2015-03-06       Impact factor: 6.918

6.  Piglets produced from cloned blastocysts cultured in vitro with GM-CSF.

Authors:  Kiho Lee; Bethany K Redel; Lee Spate; Jennifer Teson; Alana N Brown; Kwang-Wook Park; Eric Walters; Melissa Samuel; Clifton N Murphy; Randall S Prather
Journal:  Mol Reprod Dev       Date:  2013-01-22       Impact factor: 2.609

7.  Role of granulocyte/macrophage colony-stimulating factor in zymocel-induced hepatic granuloma formation.

Authors:  A A Wynn; K Miyakawa; E Miyata; G Dranoff; M Takeya; K Takahashi
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 8.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

9.  Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.

Authors:  Shiqiu Xiong; Andrew M Sharkey; Philippa R Kennedy; Lucy Gardner; Lydia E Farrell; Olympe Chazara; Julien Bauer; Susan E Hiby; Francesco Colucci; Ashley Moffett
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

10.  Csf2 null mutation alters placental gene expression and trophoblast glycogen cell and giant cell abundance in mice.

Authors:  Amanda N Sferruzzi-Perri; Anne M Macpherson; Claire T Roberts; Sarah A Robertson
Journal:  Biol Reprod       Date:  2009-02-18       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.